Cormorant Global Healthcare Master Fund, LP

Former 10% Owner, MoonLake Immunotherapeutics

Bought, 12 months

$0.0M

Sold, 12 months

$0.0M

Companies

Latest trade

Sep 30, 2025

Companies

MoonLake ImmunotherapeuticsFormer 10% Owner −$46.9M

Trades

MLTX Sold 5,827 shares at $6.96 $0.0M Sep 30

MLTX Sold 6,494,151 shares at $7.21 $46.8M Sep 29

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.